Journal Home
Search for

Volume 90, Issue 9, Pages 1469-1477 (September 2009)


View previous. 7 of 35 View next.

Validation of the Revised Quick Cognitive Screening Test

Presented to the Canadian Colloquium on Dementia, Vancouver, BC, Canada, October 18–20, 2007.

C. Charles Mate-Kole, PhDaCorresponding Author Informationemail address, James Conway, PhDa, Katherine Catayong, MAab, Rachel Bieu, MAab, Naa Amerley Sackey, BAc, Rebecca Wood, PhDa, Robert Fellows, MAa

Abstract 

Mate-Kole CC, Conway J, Catayong K, Bieu R, Sackey NA, Wood R, Fellows R. Validation of the revised Quick Cognitive Screening Test.

Objective

To validate the revised version of the Quick Cognitive Screening Test (QCST).

Design

Cross-sectional.

Setting

Senior homes; hospital; college campus.

Participants

Participants (N=377; 114 men, 263 women) were recruited comprising healthy controls (n=201; 40 men, 161 women), subjects with dementia (n=93; 34 men, 59 women) including Alzheimer disease (n=73) and vascular dementia (n=20); subjects with psychiatric illness (n=35, 15 men, 20 women), specifically schizophrenia or bipolar disorder; and subjects with other neurologic conditions (n=48, 25 men, 23 women) such as traumatic brain injury (n=12) and cerebrovascular disease (n=31). Diagnoses were confirmed by physicians using appropriate criteria. Recruitment was done in the northeastern region.

Interventions

Not applicable.

Main Outcome Measures

In an effort to examine the reliability and validity of the revised QCST, participants were administered the revised QCST with a number of standardized measures (ie, Alzheimer's Disease Assessment Scale-Cognitive, Mini-Mental State Examination, Tests of Oral Fluency, Trail-Making Test, and Functional Activities Questionnaire).

Results

The results revealed that the revised QCST discriminated between healthy controls and the neuropsychiatric participants. Additionally, the revised QCST significantly correlated with other standardized measures, confirming the revised QCST's reliability and validity as a screening instrument for subjects with cognitive deficits.

Conclusions

The revised QCST provides the clinician with a short yet reliable screening instrument in detecting cognitive deficits in subjects with dementia and other neurologic conditions.

a Department of Psychology, Central Connecticut State University, New Britain, CT

b Olin Neuropsychiatry Research Center, The Institute of Living, Hartford, CT

c Department of Public Health, Drexel University, PA

Corresponding Author InformationReprint requests to C. Charles Mate-Kole, PhD, Dept of Psychology, Central Connecticut State University, 1615 Stanley St, New Britain, CT 06050

 Supported by the Central Connecticut State University American Association of University Professors.

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated.

PII: S0003-9993(09)00285-8

doi:10.1016/j.apmr.2009.02.007


View previous. 7 of 35 View next.